STRUCTURE-FUNCTION ANALYSIS OF THE TRANSMEMBRANE DOMAIN OF DAB389-INTERLEUKIN-2, AN INTERLEUKIN-2 RECEPTOR-TARGETED FUSION TOXIN - THE AMPHIPATHIC HELICAL REGION OF THE TRANSMEMBRANE DOMAIN IS ESSENTIAL FOR THE EFFICIENT DELIVERY OF THE CATALYTIC DOMAIN TO THE CYTOSOL OF TARGET-CELLS
Jc. Vanderspek et al., STRUCTURE-FUNCTION ANALYSIS OF THE TRANSMEMBRANE DOMAIN OF DAB389-INTERLEUKIN-2, AN INTERLEUKIN-2 RECEPTOR-TARGETED FUSION TOXIN - THE AMPHIPATHIC HELICAL REGION OF THE TRANSMEMBRANE DOMAIN IS ESSENTIAL FOR THE EFFICIENT DELIVERY OF THE CATALYTIC DOMAIN TO THE CYTOSOL OF TARGET-CELLS, The Journal of biological chemistry, 268(16), 1993, pp. 12077-12082
Cassette and deletion mutagenesis were used to analyze the function of
the amphipathic alpha-helices in the transmembrane domain of DAB389-i
nterleukin-2 (IL-2), a fusion protein which is targeted to the interle
ukin-2 receptor. We demonstrate that the in-frame deletion of 60 amino
acids, from Asn204 to Glu263 in DAB389-IL-2, results in complete loss
of cytotoxic activity, whereas when the amphipathic regions from Asp2
08 to Ser220 and Ala244 to His258 are replaced with idealized amphipat
hic helices composed of repeating Glu, Lys, and Leu residues, the muta
nt fusion toxin has low but detectable activity. DAB389-IL-2 and both
variants form channels in artificial phospholipid bilayers with conduc
tances identical to those formed by diphtheria toxin. Both mutant fusi
on toxins bind to the high affinity IL-2 receptor with affinities simi
lar to that of DAB389-IL-2. The fact that these mutants have markedly
reduced or absent cytotoxic activity, but possess ''wild type'' cataly
tic activity, binding affinities, and channel conductances, suggests t
he existence of a step in the intoxication pathway, defective in the m
utants, which occurs after DAB389-IL-2 binds to the IL-2 receptor. It
is unknown whether this step occurs prior or subsequent to channel for
mation, but it is essential for the efficient delivery of the ADPL-rib
osyltransferase from DAB389-IL-2 to the cytosol of target cells.